- Home
- GDO vs NSPR Comparison
GDO vs NSPR Comparison
Compare GDO & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDO
- NSPR
- Stock Information
- Founded
- GDO 2009
- NSPR 2005
- Country
- GDO United States
- NSPR United States
- Employees
- GDO N/A
- NSPR N/A
- Industry
- GDO Finance Companies
- NSPR Medical/Dental Instruments
- Sector
- GDO Finance
- NSPR Health Care
- Exchange
- GDO Nasdaq
- NSPR Nasdaq
- Market Cap
- GDO 86.3M
- NSPR 75.1M
- IPO Year
- GDO N/A
- NSPR N/A
- Fundamental
- Price
- GDO $11.71
- NSPR $2.44
- Analyst Decision
- GDO
- NSPR Strong Buy
- Analyst Count
- GDO 0
- NSPR 2
- Target Price
- GDO N/A
- NSPR $4.50
- AVG Volume (30 Days)
- GDO 39.4K
- NSPR 386.2K
- Earning Date
- GDO 01-01-0001
- NSPR 08-05-2025
- Dividend Yield
- GDO 9.81%
- NSPR N/A
- EPS Growth
- GDO N/A
- NSPR N/A
- EPS
- GDO N/A
- NSPR N/A
- Revenue
- GDO N/A
- NSPR $7,027,000.00
- Revenue This Year
- GDO N/A
- NSPR $4.85
- Revenue Next Year
- GDO N/A
- NSPR $113.47
- P/E Ratio
- GDO N/A
- NSPR N/A
- Revenue Growth
- GDO N/A
- NSPR 8.49
- 52 Week Low
- GDO $11.21
- NSPR $1.99
- 52 Week High
- GDO $13.04
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- GDO 62.04
- NSPR 54.16
- Support Level
- GDO $11.70
- NSPR $2.12
- Resistance Level
- GDO $11.83
- NSPR $2.46
- Average True Range (ATR)
- GDO 0.09
- NSPR 0.16
- MACD
- GDO -0.00
- NSPR 0.01
- Stochastic Oscillator
- GDO 63.27
- NSPR 73.33
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.